Currently out of the existing stock ratings of Jonathan Yon, 4 are a HOLD (28.57%), 10 are a BUY (71.43%).

Jonathan Yon

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Yon, currently employed at UBS, carries an average stock price target met ratio of 66.67% that have a potential upside of 24.84% achieved within 379 days. Previously, Jonathan Yon worked at CREDIT SUISSE.

Jonathan Yon’s has documented 28 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CLOV, Clover Health Investments Corp at 24-Feb-2025.

Wall Street Analyst Jonathan Yon

Analyst best performing recommendations are on OMI (OWENS & MINOR).
The best stock recommendation documented was for OMI (OWENS & MINOR) at 8/8/2023. The price target of $19 was fulfilled within 1 day with a profit of $0.14 (0.74%) receiving and performance score of 7.42.

Average potential price target upside

CLOV Clover Health Investments Corp MD Mednax OMI Owens & Minor PRVA Privia Health Group UHS Universal Health Services

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Oct-2024

$5

$0.62 (14.16%)

$4.75

1 months 27 days ago
(06-Aug-2026)

8/8 (100%)

$0.34 (7.30%)

38

Buy Since 03-Feb-2022

$5.5

$1.12 (25.57%)

$4.2

2 months 12 days ago
(21-Jul-2026)

12/15 (80%)

$0.71 (14.82%)

228

Hold Since 19-Jan-2022

$2.5

$-2.91 (-53.79%)

$3

6 months 28 days ago
(05-Mar-2026)

6/6 (100%)

$0.43 (20.77%)

35

Hold Since 07-Oct-2024

$3

$-2.41 (-44.55%)

$4.5

1 years 1 months 27 days ago
(06-Aug-2025)

5/6 (83.33%)

$0.74 (32.74%)

117

Hold Since 10-Jan-2022

$1.5

$-2.88 (-65.75%)

$1.8

3 years 1 months 4 days ago
(29-Aug-2023)

5/6 (83.33%)

$0.13 (9.49%)

485

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Jonathan Yon?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?